These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19027976)

  • 1. Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function.
    Atoh K; Itoh H; Haneda M
    Diabetes Res Clin Pract; 2009 Feb; 83(2):220-6. PubMed ID: 19027976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum indoxyl sulfate is a useful predictor for progression of chronic kidney disease].
    Namba S; Okuda Y; Morimoto A; Kojima T; Morita T
    Rinsho Byori; 2010 May; 58(5):448-53. PubMed ID: 20560454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.
    Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S
    Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
    Niwa T; Ise M
    J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.
    Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T
    J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.
    Niwa T; Tsukushi S; Ise M; Miyazaki T; Tsubakihara Y; Owada A; Shiigai T
    Miner Electrolyte Metab; 1997; 23(3-6):179-84. PubMed ID: 9387112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction.
    Aso Y; Suganuma R; Wakabayashi S; Hara K; Nakano T; Suetsugu M; Matsumoto S; Nakamachi T; Takebayashi K; Morita K; Inukai T
    Transl Res; 2009 Oct; 154(4):175-82. PubMed ID: 19766961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy.
    Kimura T; Ikeda H; Fujikawa J; Nomura K; Aoyama T; Wada Y; Nabe K; Hamamoto Y; Honjo S; Koshiyama H
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e58-61. PubMed ID: 19118914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease.
    Taki K; Niwa T
    J Ren Nutr; 2007 Jan; 17(1):48-52. PubMed ID: 17198932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].
    Guimarães J; Bastos M; Melo M; Carvalheiro M
    Acta Med Port; 2007; 20(2):145-50. PubMed ID: 17868520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia is common and predicts mortality in diabetic nephropathy.
    Joss N; Patel R; Paterson K; Simpson K; Perry C; Stirling C
    QJM; 2007 Oct; 100(10):641-7. PubMed ID: 17921197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin concentrations are closely linked to renal function in patients with type 1 or 2 diabetes mellitus.
    Wolf G; Müller N; Hunger-Battefeld W; Kloos C; Müller UA
    Kidney Blood Press Res; 2008; 31(5):313-21. PubMed ID: 18791327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis.
    Takayama F; Taki K; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S142-5. PubMed ID: 12612972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease.
    Lin CJ; Liu HL; Pan CF; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ
    Arch Med Res; 2012 Aug; 43(6):451-6. PubMed ID: 22885091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of hemoglobin levels in patients with type 2 diabetes.
    Thomas MC; Tsalamandris C; MacIsaac RJ; Jerums G
    Am J Kidney Dis; 2006 Oct; 48(4):537-45. PubMed ID: 16997049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.